Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
The Conversation logo

Meat makes a meal, so goes the saying. But with more people than ever before ditching meat for plant-based alternatives, it seems meaty dishes are starting to go out of fashion.

An estimated 29% of evening meals contained no meat or fish in 2017, according to UK market research. And the reason for this is often linked to health. Research shows that eating red and processed meat is associated with an increased risk of heart diseasetype 2 diabetes, and bowel cancer.

Livestock production is also bad for the environment. It leads to deforestation, pollution of water, and emits greenhouse gases that heat up our planet. This environmental impact also takes a toll on human health – for example, a warmer climate enables malaria-carrying mosquitoes to spread faster and wider.

But despite the rise of lower meat diets, scientists continue to call for more people to reduce their meat consumption, which is essential to meet environmental and climate change targets.

Read the full article on The Conversation website, written by Filippo Bianchi, research student in the Nuffield Department of Primary Care Health Sciences. 

Oxford is a subscribing member of The ConversationFind out how you can write for The Conversation.

Similar stories

Singula Bio, a new Oxford spin-out company - Cancer need not be fatal

General Innovation Research

Singula Bio, a bold new seed-stage biotechnology company spun out of Oxford University, has been launched with the intention of helping show that cancer need not be fatal. Led by three Oxford cancer specialists, the firm is aims to become a world leader in therapies to use against difficult-to-treat solid malignancies such as ovarian cancer - using the body’s own immune system to fight previously fatal cancers.

Major rise in public support for COVID vaccine – Oxford study

Coronavirus COVID-19 General Research

More than three quarters of people in the UK now say they are ’very likely’ to have the vaccine – up from 50% among the same group of survey respondents five months ago –according to a two-wave Oxford University survey published today.

Coronavirus vaccination linked to substantial reduction in hospitalisation, real-world data suggests

Coronavirus COVID-19 General Research

The first study to describe the effects in real-world communities of the Oxford coronavirus vaccine has been reported in a pre-print publication today, showing a clear reduction in the risk of hospitalisation from COVID-19 amongst those who have received the vaccine.

Reprogramming tumour cells using an antimalarial drug

General Research

Results from the ATOM clinical trial at the University of Oxford have shown that the anti-malarial drug Atovaquone can reduce very low oxygen tumour environments. This has the potential to make cancers behave less aggressively and to improve the impact of everyday cancer treatments.

Oxford-led technology to help those at high risk from Covid-19

Coronavirus COVID-19 General Research

More people in England at high risk from Covid-19 will get priority access to vaccines thanks to new technology developed by a University of Oxford-led team of researchers that can identify those who may be most vulnerable to the virus.